Nightmares Associated to Nevirapine during Chemoradiotherapy for Carcinoma Tongue
International Journal of Medical and Pharmaceutical Case Reports · pp. 28–31 · Published 11 Apr 2024
10.9734/ijmpcr/2024/v17i2372Abstract
Nevirapine, a non-nucleoside reverse transcriptase inhibitor (NNRTI) is a drug used in the management and treatment of HIV. It is considered safe for use in conjunction with platinum-based chemotherapy. Chemotherapy is a staple of cancer treatment and is used routinely in the management of malignancies of the head and neck. However, managing HIV-positive cancers presents challenges due to individual side effects and drug interactions. Drug interactions can potentiate or reduce drug metabolism, reduce excretion, or cause adverse drug reactions. Herein, we describe a case of new-onset nevirapine-induced nightmares that was noted in a patient undergoing chemoradiotherapy with cisplatin.
Cited by 0
No indexed citations yet.
Related research
- Primary Mucinous Carcinoma of the Skin: Report of a Rare Case and Review of the Literature — shares topic coverage
- Chediak-Higashi Syndrome: A Case Presenting in Accelerated Phase — shares topic coverage
- Hemoadsorption with CytoSorb in Pediatric Patient of Dengue Shock Syndrome: A Case Report — shares topic coverage
- A Case Report on Arnold Chiari Type III: Constellation of Disorders, from Diagnosis to Treatment — shares topic coverage
- Takayasu's Arteritis with Aortic Insufficiency as Initial Presentation: A Case Report — shares topic coverage
Article metrics
Real usage data collected on this platform.
0
Page views
0
PDF downloads
0
Outbound clicks
0
Citations
Views by country
Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".
No views recorded yet.
Traffic sources
Referring site, by host.
No traffic recorded yet.
Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.